IMV

1D
1W
1M
3M
1Y
5Y

Why Robinhood?

Robinhood gives you the tools you need to put your money in motion. You can buy or sell IMV and other ETFs, options, and stocks.

About IMV

IMV, Inc. is a clinical-stage biopharmaceutical company, which engaged in providing a novel class of cancer immunotherapies and vaccines against infectious diseases including COVID-19. The firm leverages its delivery platform (DPX) that programs immune cells directly within the human body to produce robust and sustained target killing capabilities. 

CEO
Andrew Hall
CEOAndrew Hall
Employees
97
Employees97
Headquarters
Dartmouth, Nova Scotia
HeadquartersDartmouth, Nova Scotia
Founded
2007
Founded2007
Employees
97
Employees97

IMV Key Statistics

Market cap
21.09M
Market cap21.09M
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
60.34K
Average volume60.34K
High today
High today
Low today
Low today
Open price
$0.27
Open price$0.27
Volume
0.00
Volume0.00
52 Week high
$1.60
52 Week high$1.60
52 Week low
$0.2408
52 Week low$0.2408

IMV Earnings

-$0.15
-$0.10
-$0.05
$0.00
Q1 FY21
Q2 FY21
Q3 FY21
Q4 FY21
Q1 FY22
Q2 FY22
Q3 FY22
Q4 FY22
Estimated
per share
Estimated per share
Actual
Expected Mar 16, After Hours
ActualExpected Mar 16, After Hours
All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer.